Curis (CRIS) Non-Current Assets (2010 - 2026)
Curis (CRIS) reported Non-Current Assets of $13.1 million for Q1 2026, down 9.92% on a YoY basis from $14.5 million in Q1 2025, and little changed quarter-over-quarter from $13.1 million in Q4 2025.
Curis (CRIS) Non-Current Assets (2010 - 2026) Analysis & Trends
Curis has reported Non-Current Assets for 17 years, with the latest figure at $13.1 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 9.92% year-over-year to $13.1 million; the trailing twelve-month figure through Mar 2026 stood at $54.7 million (down 10.1% YoY), and the FY2025 full-year result was $13.1 million, down 12.29% from the prior year.
- Non-Current Assets for Q1 2026 stood at $13.1 million, roughly flat from $13.1 million in the prior quarter.
- The five-year high for Non-Current Assets was $17.1 million in Q3 2022, with the low at $13.1 million in Q4 2025.
- Historically, Non-Current Assets has averaged $15.4 million across 5 years, with a median of $15.5 million in 2024.
- Annual changes were most pronounced in 2022 — Non-Current Assets plunged 58.1% — and 2023, when it climbed 13.25%.
- Curis' Non-Current Assets stood at $16.7 million in 2022, then dropped by 2.12% to $16.4 million in 2023, then declined by 9.12% to $14.9 million in 2024, then dropped by 12.29% to $13.1 million in 2025, then advanced by 0.18% to $13.1 million in 2026.
- The last three Non-Current Assets figures came in at $13.1 million (Q1 2026), $13.1 million (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 62,953.78 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 39.71 Mn |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | 13.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.08 Mn |
| Dec 31, 2025 | 13.05 Mn |
| Sep 30, 2025 | 13.73 Mn |
| Jun 30, 2025 | 14.82 Mn |
| Mar 31, 2025 | 14.52 Mn |
| Dec 31, 2024 | 14.88 Mn |
| Sep 30, 2024 | 15.54 Mn |
| Jun 30, 2024 | 15.89 Mn |
| Mar 31, 2024 | 15.96 Mn |
| Dec 31, 2023 | 16.37 Mn |
| Sep 30, 2023 | 16.55 Mn |
| Jun 30, 2023 | 16.46 Mn |
| Mar 31, 2023 | 16.53 Mn |
| Dec 31, 2022 | 16.73 Mn |
| Sep 30, 2022 | 17.14 Mn |
| Jun 30, 2022 | 15.44 Mn |
| Mar 31, 2022 | 14.60 Mn |
| Dec 31, 2021 | 39.93 Mn |
| Sep 30, 2021 | 37.14 Mn |
| Jun 30, 2021 | 24.66 Mn |